BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21198702)

  • 1. Midodrine and furosemide-induced natriuresis in cirrhotics with ascites.
    Kalambokis G; Tsianos EV
    Aliment Pharmacol Ther; 2011 Feb; 33(3):415-6. PubMed ID: 21198702
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.
    Misra VL; Vuppalanchi R; Jones D; Hamman M; Kwo PY; Kahi C; Chalasani N
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1044-50. PubMed ID: 20937051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of furosemide on liver cirrhosis patients with ascites].
    De Los Reyes MP; Bardi A; Carrillo E; Generini G
    Rev Med Chil; 1966 Mar; 94(3):149-54. PubMed ID: 5986934
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
    Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
    J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R; Woodis CB
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study.
    Rai N; Singh B; Singh A; Vijayvergiya R; Sharma N; Bhalla A; Singh V
    Liver Int; 2017 Mar; 37(3):406-414. PubMed ID: 27614145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
    Brater DC; Chalasani N; Gorski JC; Horlander JC; Craven R; Hoen H; Maya J
    Trans Am Clin Climatol Assoc; 2001; 112():108-15; discussion 116. PubMed ID: 11413770
    [No Abstract]   [Full Text] [Related]  

  • 11. Propranolol in the treatment of cirrhotic ascites.
    Rector WG; Reynolds TB
    Arch Intern Med; 1984 Sep; 144(9):1761-3. PubMed ID: 6476994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P; Fauvert R
    Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of hepatic ascites using Fursemide].
    Bemvenuti GA; Job JM
    Hospital (Rio J); 1968 Nov; 74(5):1601-38. PubMed ID: 5305338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical trial of the association of furosemide and triamterene].
    Azzi E; Perraro F
    Clin Ter; 1971 Mar; 56(6):501-22. PubMed ID: 5131091
    [No Abstract]   [Full Text] [Related]  

  • 15. [Furosemide in treatment of the edema syndrome in cirrhotics].
    Nuti M
    Clin Ter; 1965 Sep; 34(6):507-14. PubMed ID: 5852544
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
    Ali A; Farid S; Amin M; Kassem M; Al-Garem N
    Hepatogastroenterology; 2014 Oct; 61(135):1915-24. PubMed ID: 25713888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aldosterone and renin in liver cirrhosis with ascites].
    Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites.
    Kountouras J; Zavos C; Touloumis L; Chatzopoulos D
    Liver Int; 2010 Oct; 30(9):1395; author reply 1395-6. PubMed ID: 20731771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical program of therapy for ascitic edema in liver disease].
    Pupita F; Ansuini R; Frausini G
    Clin Ter; 1982 Jan; 100(2):115-33. PubMed ID: 7186421
    [No Abstract]   [Full Text] [Related]  

  • 20. [The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
    Ventura E; Zeneroli ML
    Folia Endocrinol; 1969 Dec; 22(4):345-53. PubMed ID: 4329093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.